Evolent Health, Inc.
$2.93
▲
1.35%
2026-04-21 06:44:01
www.evolent.com
NYQ: EVH
Explore Evolent Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$327.1 M
Current Price
$2.93
52W High / Low
$12.06 / $2.1
Stock P/E
—
Book Value
$3.72
Dividend Yield
—
ROCE
-1.31%
ROE
-66.54%
Face Value
—
EPS
$-5.07
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
4,200
Beta
0.37
Debt / Equity
238.37
Current Ratio
1.31
Quick Ratio
1.31
Forward P/E
5.27
Price / Sales
0.14
Enterprise Value
$1.1 B
EV / EBITDA
12.45
EV / Revenue
0.58
Rating
Strong Buy
Target Price
$5.18
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Privia Health Group, Inc. | $24.08 | 131.66 | $3.02 B | — | 4.27% | 4.03% | $26.51 / $18.77 | $5.96 |
| 2. | OptimizeRx Corporation | $7.2 | 26.21 | $134.53 M | — | 7.75% | 4.18% | $22.25 / $5.54 | $6.84 |
| 3. | So-Young International Inc. | $2.9 | — | $283.61 M | 0% | -4.01% | -13.61% | $6.28 / $0.74 | $2.25 |
| 4. | Health Catalyst, Inc. | $1.26 | — | $92.72 M | — | -10.35% | -58.26% | $5.06 / $0.96 | $3.41 |
| 5. | Talkspace, Inc. | $5.18 | 111.06 | $865.45 M | — | 2.68% | 6.65% | $5.2 / $2.22 | $0.7 |
| 6. | Waystar Holding Corp. | $26.71 | 45.13 | $5.06 B | — | 4.48% | 3.22% | $42.55 / $20.93 | $20.25 |
| 7. | American Well Corporation | $6.61 | — | $101.3 M | — | -42.01% | -33.67% | $9.15 / $3.71 | $14.34 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 468.72 M | 479.53 M | 444.33 M | 483.65 M | 646.54 M | — |
| Operating Profit | -20.44 M | -1.43 M | 2.04 M | 0 M | -1.29 M | — |
| Net Profit | -429.13 M | -20.86 M | -19.9 M | -64.62 M | -22.8 M | — |
| EPS in Rs | -3.84 | -0.19 | -0.18 | -0.58 | -0.2 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.88 B | 2.55 B | 1.96 B | 1.35 B |
| Operating Profit | -19.83 M | -14.07 M | -21.05 M | -19.88 M |
| Net Profit | -534.51 M | -61.62 M | -113.04 M | -19.16 M |
| EPS in Rs | -4.79 | -0.55 | -1.01 | -0.17 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.9 B | 2.54 B | 2.68 B | 1.82 B |
| Total Liabilities | 1.48 B | 1.54 B | 1.61 B | 957.88 M |
| Equity | 415.19 M | 1 B | 1.07 B | 859.42 M |
| Current Assets | 506.37 M | 607.12 M | 683.67 M | 478.05 M |
| Current Liabilities | 385.26 M | 715.5 M | 674.24 M | 433.44 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 38.84 M | 18.77 M | 142.58 M | -11.55 M |
| Investing CF | -0.23 M | -62.93 M | -415.54 M | -259.12 M |
| Financing CF | -35.92 M | -0.56 M | 281.34 M | 131.54 M |
| Free CF | 4.75 M | -6.13 M | 113.84 M | -49.91 M |
| Capex | -34.09 M | -24.89 M | -28.75 M | -38.36 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 30.09% | 45.26% | — | — |
| Earnings Growth % | 45.49% | -489.86% | — | — |
| Profit Margin % | -2.41% | -5.76% | -1.42% | — |
| Operating Margin % | -0.55% | -1.07% | -1.47% | — |
| Gross Margin % | 14.38% | 23.45% | 23.42% | — |
| EBITDA Margin % | 3.13% | -1.26% | 1.53% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.